According to Perrigo's latest financial reports the company's current earnings (TTM) are $0.35 B. In 2021 the company made an earning of $0.38 B an increase over its 2020 earnings that were of -$0.03 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2022 (TTM) | $0.35 B | -6.83% |
2021 | $0.38 B | -1672.54% |
2020 | -$0.03 B | -105.87% |
2019 | $0.41 B | -13.78% |
2018 | $0.48 B | -31.81% |
2017 | $0.70 B | 6.72% |
2016 | $0.66 B | -13.34% |
2015 | $0.76 B | 16.39% |
2014 | $0.65 B | -0.51% |
2013 | $0.65 B | 4.2% |
2012 | $0.63 B | 24.43% |
2011 | $0.50 B | 24.04% |
2010 | $0.41 B | 43.71% |
2009 | $0.28 B | 9.09% |
2008 | $0.26 B | 74.66% |
2007 | $0.14 B | 32.73% |
2006 | $0.11 B | 56.84% |
2005 | $0.07 B | -19.63% |
2004 | $0.08 B | -3.93% |
2003 | $0.09 B | -9.74% |
2002 | $0.10 B | 34.81% |
2001 | $0.07 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() United Therapeutics UTHR | $0.88 B | 148.62% | ๐บ๐ธ USA |
![]() Endo International
ENDP | -$0.1 B | -127.46% | ๐ฎ๐ช Ireland |
![]() Intercept Pharmaceuticals
ICPT | -$0.03 B | -106.01% | ๐บ๐ธ USA |
![]() Catalent CTLT | $0.73 B | 106.55% | ๐บ๐ธ USA |